World's Best Scientists 2026 revealed!
John A. Lust

John A. Lust

D-Index & Metrics

Medicine

D-Index
104
Citations
42895
World Ranking
7015
National Ranking
3685

John A. Lust publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John A. Lust sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 526 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John A. Lust D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John A. Lust sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John A. Lust is affiliated with the Mayo Clinic in the United States and is an active researcher focusing on Medicine, particularly in areas relating to Biochemistry, Genetics, and Molecular Biology. Their work spans a significant number of publications, emphasizing multiple facets of hematologic diseases and molecular mechanisms.

The scientist's expertise covers several main fields and subfields, including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Molecular Biology
  • Hematology
  • Oncology
  • Genetics
  • Nephrology

John A. Lust's research topics focus on:

  • Multiple Myeloma Research and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Protein Degradation and Inhibitors
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Parathyroid Disorders and Treatments
  • Glycosylation and Glycoproteins Research

Their recent published papers include:

  • Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response, 2020, Blood Cancer Journal
  • Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities, 2020, Blood Advances
  • Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update, 2021, Mayo Clinic Proceedings
  • Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma, 2020, Clinical Cancer Research
  • MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients, 2021, Blood Cancer Journal

Frequent co-authors working with John A. Lust include:

  • Angela Dispenzieri
  • Taxiarchis Kourelis
  • Morie A. Gertz
  • Shaji Kumar
  • S. Vincent Rajkumar

Publication venues where John A. Lust has frequently contributed are:

  • Blood
  • Blood Cancer Journal
  • Blood Advances
  • American Journal of Hematology
  • Mayo Clinic Proceedings

Best Publications

  • Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

    Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • POEMS syndrome: definitions and long-term outcome.

    Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;S. Vincent Rajkumar

  • A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine

    Robert A. Kyle;Morie A. Gertz;Philip R. Greipp;Thomas E. Witzig

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

    S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri

  • Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

    S. Vincent Rajkumar;Suzanne Hayman;Morie A. Gertz;Angela Dispenzieri

  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

    Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli

  • Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

    John A. Lust;Kathleen A. Donovan;Michael P. Kline;Philip R. Greipp

  • Genomic abnormalities in monoclonal gammopathy of undetermined significance

    Rafael Fonseca;Richard J. Bailey;Gregory J. Ahmann;S. Vincent Rajkumar

  • Clinical course of patients with relapsed multiple myeloma.

    Shaji K. Kumar;Terry M. Therneau;Morie A. Gertz;Martha Q. Lacy

  • Plasma cell labeling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma

    PR Greipp;JA Lust;WM O'Fallon;JA Katzmann

  • Prognostic Value of Bone Marrow Angiogenesis in Multiple Myeloma

    S V Rajkumar;T Leong;P C Roche;R Fonseca

  • Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma

    Martha Q. Lacy;Suzanne R. Hayman;Morie A. Gertz;Angela Dispenzieri

  • Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • Screening panels for detection of monoclonal gammopathies.

    Jerry A. Katzmann;Robert A. Kyle;Joanne Benson;Dirk R. Larson

  • Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?

    Madhav V. Dhodapkar;Chin Yang Li;John A. Lust;Ayalew Tefferi

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Commentary

    Michele Cavo;S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As medical careers continue to evolve, many students are exploring online degrees to broaden their expertise and improve career flexibility. There are now a variety of accredited programs available for those who want to make an impact in healthcare—without attending traditional, on-campus classes.

For those interested in healthcare leadership, pursuing one of the cheapest online mha programs can provide critical management skills at an affordable cost. Meanwhile, nurses aiming for the highest level of clinical practice can look into the cheapest dnp online programs.

Pharmacists seeking advanced credentials may benefit from researching the best online pharmacy school options that fit their budget and career goals. Additionally, health informatics professionals are in high demand; you can accelerate your expertise by choosing an online mhi degree for specialized training in managing healthcare data.

Exploring these online degrees allows you to find flexible, affordable pathways that align with your ambitions and can complement your journey toward a medical career in the USA.

Best Scientists Citing John A. Lust

Trending Scientists

Recently Published Articles